Table 1.
Baseline characteristics in the patients with Graves' disease, subacute thyroiditis and toxic adenoma/multinodular goiter.
| Graves' disease (N = 468) | Subacute thyroiditis (N = 40) | Toxic adenoma/multinodular goiter (N = 40) | |
|---|---|---|---|
| Mean age (years) | 42.35 ± 12.52 | 51.94 ± 20.55 | 44.32 ± 15.02 |
| Female (%) | 79.3% | 75% | 82.5% |
| Signs (%) | |||
| Goiter | 56.2% | 35% | 66.7% |
| Ophthalmopathy | 14.7% | 0% | 0% |
| Acropachy | 0.6% | 0% | 0% |
| Pretibial myxedema | 0.4% | 0% | 0% |
| Thyroid function tests | |||
| Mean FT3 (pg/mL) | 15.72 ± 10.1 | 5.56 ± 2.99 | 5.29 ± 3.81 |
| Mean FT4 (ng/dL) | 3.22 ± 1.31 | 2.00 ± 0.63 | 1.86 ± 0.48 |
| Median TSH (mIU/L, IQR) | 0.0038 (0.0038–0.0038) | 0.01 (0.006–0.028) | 0.0038 (0.0038–0.032) |
| Mean FT3/FT4 (10−2 pg/ng) | 4.62 ± 2 | 2.73 ± 0.5 | 2.67 ± 1.3 |
Abbreviations: FT3, free triiodothyronine; FT4, free thyroxine; IQR, interquartile range; TSH, thyroid-stimulating hormone.